Form 4: Dentsply Sirona Director Clyde Hosein Receives Stock Dividends

Sentiment:

SEC Form 4


Director Clyde Hosein receives stock dividends in the form of additional restricted stock units (RSUs) from Dentsply Sirona.

Summary

  • On April 12, 2024, Clyde Hosein, a director at Dentsply Sirona Inc. (XRAY), acquired 26.426 shares of common stock.
  • These shares represent dividends on restricted stock units (RSUs) awarded to Hosein.
  • The dividends are in the form of additional RSUs and are subject to the same vesting terms as the underlying awards.
  • The price of the acquired stock was $0.
  • Following the transaction, Hosein beneficially owns 18,286.7955 shares of Dentsply Sirona common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and alignment of interests.

Positives

  • The receipt of stock dividends indicates continued investment and alignment of interests between the director and the company's performance.

Future Outlook

The RSUs will vest according to their original terms, converting to common stock on a 1:1 basis.

Industry Context

This is a routine transaction related to executive compensation and is common in publicly traded companies to align management's interests with shareholders.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.

Key Dates

DateDescription
04/12/2024Date of the transaction where Clyde Hosein acquired stock dividends.
04/15/2024Date of signature by Attorney-In-Fact for Clyde R. Hosein.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.